Zhejiang Huahai Pharmaceutical News

Prompt announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the response to the review inquiry letter on the issuance of stock application documents to specific targets and the revision of application documents such as prospectus and financial data

09-15 12:00

Letter of listing of Zheshang Securities Co., Ltd. relating to the issuance of shares by Zhejiang Huahai Pharmaceutical Co., Ltd. to specific targets

09-15 12:00

Response to the review inquiry letter on Zhejiang Huahai Pharmaceutical Co., Ltd.\'s application documents for issuing shares to specific targets (three revisions)

09-15 12:00

Explanation of financial matters in the audit inquiry letter from Tianjian Certified Public Accountants (Special General Partnership) on Zhejiang Huahai Pharmaceutical Co., Ltd.\'s application to issue shares to specific targets

09-15 12:00

Tianjian Certified Public Accountants (Special General Partnership) Financial Report and Audit Report on Zhejiang Huahai Pharmaceutical Co., Ltd.\'s issuance of shares to specific targets

09-15 12:00

Zhejiang Huahai Pharmaceutical Co., Ltd. issues stock raising instructions to specific targets (application draft) (revised draft)

09-15 12:00

Letter of sponsorship from Zheshang Securities Co., Ltd. relating to the issuance of shares by Zhejiang Huahai Pharmaceutical Co., Ltd. to specific targets

09-15 12:00

Supplementary Legal Opinion of Zhejiang Tianze Law Firm on Zhejiang Huahai Pharmaceutical Co., Ltd.\'s issuance of A-shares to specific targets (4)

09-15 12:00

Announcement of Resolutions of the 2023 Second Extraordinary General Meeting of Shareholders of Zhejiang Huahai Pharmaceutical Co., Ltd.

09-06 12:00

Legal opinion of Zhejiang Tianze Law Firm on the 2023 Second Extraordinary General Meeting of Shareholders of Zhejiang Huahai Pharmaceutical Co., Ltd.

09-06 12:00

Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on holding the 2023 semi-annual results briefing

09-05 12:00

Announcement of Zhejiang Huahai Pharmaceutical Co., Ltd. on the approval number of the US FDA for the pharmaceutical product dicycloamine hydrochloride capsules

09-02 12:00

Special report of Zhejiang Huahai Pharmaceutical Co., Ltd. on the storage and actual use of funds raised in the semi-annual period of 2023

08-31 12:00

Announcement of Resolutions of the 17th Interim Meeting of the Eighth Board of Directors of Zhejiang Huahai Pharmaceutical Co., Ltd. (Communication method)

08-31 12:00

Zhejiang Huahai Pharmaceutical Co., Ltd. Branch Company Management System

08-31 12:00

Zhejiang Huahai Pharmaceutical Co., Ltd. Semi-Annual Report for 2023

08-31 12:00

Announcement of Resolutions of the 10th Interim Meeting of the Eighth Board of Supervisors of Zhejiang Huahai Pharmaceutical Co., Ltd. (Communication method)

08-31 12:00

Summary of the 2023 semi-annual report of Zhejiang Huahai Pharmaceutical Co., Ltd.

08-31 12:00

Information on the 2023 Second Extraordinary General Meeting of Shareholders of Zhejiang Huahai Pharmaceutical Co., Ltd.

08-30 12:00

Prompt Notice of Zhejiang Huahai Pharmaceutical Co., Ltd. on Convening the Second Extraordinary General Meeting of Shareholders in 2023

08-30 12:00